Detalhe da pesquisa
1.
High-Grade, Nonsarcomatoid Chromophobe Renal Cell Carcinoma: A Series of 22 Cases With Novel Molecular Features on a Subset.
Mod Pathol
; 37(5): 100472, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38492778
2.
NCCN Guidelines® Insights: Kidney Cancer, Version 2.2024.
J Natl Compr Canc Netw
; 22(1): 4-16, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38394781
3.
Beyond the knife: strategic patient selection for cytoreductive nephrectomy.
Curr Opin Urol
; 34(3): 210-216, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38240477
4.
Molecular differences in renal cell carcinoma between males and females.
World J Urol
; 41(7): 1727-1739, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36905442
5.
Self-reported quality of life as a predictor of mortality in renal cell carcinoma.
Cancer
; 128(3): 479-486, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34609761
6.
Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 20(1): 71-90, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34991070
7.
Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study.
Lancet Oncol
; 21(2): 283-293, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31870811
8.
Everolimus plus bevacizumab is an effective first-line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trial.
Cancer
; 126(24): 5247-5255, 2020 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32975815
9.
Systemic therapy for advanced clear cell renal cell carcinoma after discontinuation of immune-oncology and VEGF targeted therapy combinations.
BMC Urol
; 20(1): 84, 2020 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32616076
10.
Prognostic significance of pT3a staging subclassifications in renal cell carcinoma: Not all pT3a are equal.
Urol Oncol
; 42(4): 119.e23-119.e29, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38355353
11.
Survival outcomes and molecular drivers of testicular cancer in hispanic men.
Urol Oncol
; 2024 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38821727
12.
First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors.
Cancer Res Commun
; 4(4): 1100-1110, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38551394
13.
Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma.
Sci Rep
; 14(1): 1458, 2024 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38228729
14.
Kidney Cancer Updates from the 2023 American Society of Clinical Oncology Annual Meeting in Chicago.
Kidney Cancer J
; 21(2): 58-63, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38298522
15.
Robotic-assisted cytoreductive partial nephrectomy for metastatic sarcomatoid renal cell carcinoma following dramatic response to combination immunotherapy in a young female.
Kidney Cancer J
; 21(2): 15-18, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37981948
16.
Vascular Expression of Prostate-specific Membrane Antigen (PSMA) in MiTF Family Translocation Renal Cell Carcinoma and Related Neoplasms.
Appl Immunohistochem Mol Morphol
; 31(8): 544-549, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37471632
17.
Socioeconomic determinants of racial disparities in survival outcomes among patients with renal cell carcinoma.
Urol Oncol
; 41(11): 460.e1-460.e9, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37709565
18.
Combinatorial biomarker for predicting outcomes to anti-PD-1 therapy in patients with metastatic clear cell renal cell carcinoma.
Cell Rep Med
; 4(2): 100947, 2023 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36812889
19.
Kidney Cancer Research Highlights from ASCO 2022 Annual Meeting.
Kidney Cancer J
; 20(2): 61-64, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36479546
20.
Lenvatinib plus pembrolizumab combination therapy for adult patients with advanced renal cell carcinoma.
Expert Rev Anticancer Ther
; 22(10): 1049-1059, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36154355